Cargando…
Combination Therapy of Interferon Beta-1b and Tacrolimus: A Pilot Safety Study
Tacrolimus is a calcineurin inhibitor which works to induce immune suppression by preventing cytokine transcription and lymphocyte activation. Combining the immunomodulator interferon beta-1b (Betaseron) with the immunosuppressant tacrolimus (Prograf) may have the potential of additive therapeutic b...
Autores principales: | Jacques, F., Gaboury, I., Christie, S., Grand'Maison, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431088/ https://www.ncbi.nlm.nih.gov/pubmed/22966460 http://dx.doi.org/10.1155/2012/935921 |
Ejemplares similares
-
Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy
por: Zou, Honghong, et al.
Publicado: (2019) -
Response to Interferon-Beta Treatment in Afro-Caribbeans with Multiple Sclerosis
por: Jeannin, S., et al.
Publicado: (2011) -
The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy
por: Liang, Qian, et al.
Publicado: (2017) -
Enriching health-professional programs in global health: Development and implementation of an interdisciplinary and integrated approach
por: Valois, Carol, et al.
Publicado: (2017) -
Association between occupational exposures and sarcoma incidence and mortality: systematic review and meta-analysis
por: Edwards, D., et al.
Publicado: (2021)